Send me a link:

*Text messaging rates may apply.

 Dow Down 0.72% Nasdaq Down 0.50%

TapImmune, Inc. (TPIV)

-Other OTC
1.44 Up 0.05(3.60%) Jul 25, 3:26PM EDT
Prev Close:1.39
Open:1.40
Bid:N/A
Ask:N/A
1y Target Est:6.97
Beta:2.04
Next Earnings Date:N/A
Day's Range:1.39 - 1.45
52wk Range:1.00 - 7.00
Volume:34,981
Avg Vol (3m):10,016
Market Cap:23.23M
P/E (ttm):N/A
EPS (ttm):-13.05
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for TPIV

Comparison

Symbol% ChgMkt Cap
TPIVUp 3.60%23.23M
DNDNDown 2.28%331.94M
GSKDown 2.96%116.85B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.21
Quarterly EPS Est (Jun-14) :-0.12
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

TapImmune Inc., clinical-stage immunotherapy company, develops peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer and infectious diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback